These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28129069)

  • 21. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C
    J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consumer's Regulatory Knowledge of Prescription Drug Advertising and Health Risk Awareness: The Moderating Role of Risk Information Prominence.
    Ju I; Ohs JE; Park JS
    Health Commun; 2020 May; 35(6):696-706. PubMed ID: 30835557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asking a doctor versus referring to the Internet: A comparison study on consumers' reactions to DTC (direct-to-consumer) prescription drug advertising.
    Jiang P
    Health Mark Q; 2018; 35(3):209-226. PubMed ID: 30551729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consumers' Understanding of FDA Approval Requirements and Composite Scores in Direct-to-Consumer Prescription Drug Print Ads.
    O'Donoghue AC; Sullivan HW; Williams PA; Squire C; Betts KR; Fitts Willoughby J; Parvanta S
    J Health Commun; 2016 Aug; 21(8):927-34. PubMed ID: 27414000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of risk disclosure prominence in direct-to-consumer advertising (DTCA) of prescription drugs: An integrative cognitive process model.
    Ju I; Park JS
    Health Mark Q; 2018; 35(1):32-46. PubMed ID: 29608136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taking Repeated Exposure into Account: An Experimental Study of Direct-To-Consumer Prescription Drug Television Ad Effects.
    Betts KR; Aikin KJ; Kelly BJ; Johnson M; Parvanta S; Southwell BG; Mack N; Tzeng J; Cameron L
    J Health Commun; 2019; 24(5):503-511. PubMed ID: 31033396
    [No Abstract]   [Full Text] [Related]  

  • 27. Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration.
    Sullivan HW; Campbell M
    J Health Commun; 2015; 20(12):1391-6. PubMed ID: 26120940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trust in prescription drug brand websites: website trust cues, attitude toward the website, and behavioral intentions.
    Huh J; Shin W
    J Health Commun; 2014; 19(2):170-91. PubMed ID: 24094133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimistic bias, advertising skepticism, and consumer intentions for seeking information about the health risks of prescription medicine.
    Park JS; Ahn HA; Haley EJ
    Health Mark Q; 2017; 34(2):81-96. PubMed ID: 28590885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Use of Narratives to Deliver Information in Direct-To-Consumer Prescription Drug Commercials: A Content Analysis.
    Ball JG; Applequist J
    J Health Commun; 2019; 24(5):512-524. PubMed ID: 31256712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How direct-to-consumer drug websites convey disease information: analysis of stigma-reducing components.
    Kang H; An S
    J Health Commun; 2013; 18(12):1477-91. PubMed ID: 24015752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The unintended consequences of argument dilution in direct-to-consumer drug advertisements.
    Sivanathan N; Kakkar H
    Nat Hum Behav; 2017 Nov; 1(11):797-802. PubMed ID: 31024121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Web-Based Consumer Medication Information: Content and Usability of 4 Australian Websites.
    Raban MZ; Tariq A; Richardson L; Byrne M; Robinson M; Li L; Westbrook JI; Baysari MT
    Interact J Med Res; 2016 Jul; 5(3):e21. PubMed ID: 27443680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual images of prescription drug benefits in direct-to-consumer television advertisements.
    Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Amoozegar JB; Rupert DJ
    Patient Educ Couns; 2021 Sep; 104(9):2240-2249. PubMed ID: 33618970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consumer perceptions of prescription drug websites: a pilot study.
    Wymer W
    Health Mark Q; 2010 Apr; 27(2):173-94. PubMed ID: 20446140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of perceptions and attitudes about direct-to-consumer advertising of prescription drugs among college students in South Korea.
    Yang YM; Lee JJ; Jeong E; Kim SY; Han MA; Choi EJ
    PLoS One; 2018; 13(7):e0201108. PubMed ID: 30040833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consumer tradeoff of advertising claim versus efficacy information in direct-to-consumer prescription drug ads.
    Aikin KJ; Betts KR; Ziemer KS; Keisler A
    Res Social Adm Pharm; 2019 Dec; 15(12):1484-1488. PubMed ID: 30846370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Informing patients: the influence of numeracy, framing, and format of side effect information on risk perceptions.
    Peters E; Hart PS; Fraenkel L
    Med Decis Making; 2011; 31(3):432-6. PubMed ID: 21191122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study.
    Khalil Zadeh N; Robertson K; Green JA
    BMJ Open; 2017 Dec; 7(12):e017865. PubMed ID: 29217723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.